Osaic Holdings
RYTM icon

Osaic Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Osaic Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.7K Sell
939
-100
-10% -$9.72K ﹤0.01% 4833
2025
Q4 		$111K Buy
1,039
+59
+6% +$6.26K ﹤0.01% 4620
2025
Q3 		$99.7K Buy
980
+1
+0.1% +$93 ﹤0.01% 4781
2025
Q2 		$61.9K Buy
979
+389
+66% +$23.8K ﹤0.01% 4895
2025
Q1 		$31.3K Sell
590
-83
-12% -$4.61K ﹤0.01% 5045
2024
Q4 		$37.7K Buy
673
+5
+0.7% +$276 ﹤0.01% 4904
2024
Q3 		$35K Sell
668
-492
-42% -$23.6K ﹤0.01% 5001
2024
Q2 		$47.6K Buy
1,160
+432
+59% +$17.2K ﹤0.01% 4719
2024
Q1 		$31.5K Buy
728
+519
+248% +$22.7K ﹤0.01% 5068
2023
Q4 		$9.61K Hold
209
– – ﹤0.01% 5853
2023
Q3 		$4.79K Sell
209
-40
-16% -$896 ﹤0.01% 6292
2023
Q2 		$4.11K Buy
249
+40
+19% +$722 ﹤0.01% 6398
2023
Q1 		$3.73K Hold
209
– – ﹤0.01% 6476
2022
Q4 		$6K Hold
209
– – ﹤0.01% 6216
2022
Q3 		$5K Sell
209
-1
-0.5% -$19 ﹤0.01% 6386
2022
Q2 		$1K Hold
210
– – ﹤0.01% 7140
2022
Q1 		$2K Hold
210
– – ﹤0.01% 6909
2021
Q4 		$2K Sell
210
-600
-74% -$6.74K ﹤0.01% 7048
2021
Q3 		$11K Sell
810
-105
-11% -$1.6K ﹤0.01% 6156
2021
Q2 		$18K Sell
915
-80
-8% -$1.66K ﹤0.01% 5730
2021
Q1 		$21K Buy
995
+45
+5% +$1.3K ﹤0.01% 5441
2020
Q4 		$28K Buy
950
+75
+9% +$1.91K ﹤0.01% 4955
2020
Q3 		$19K Buy
875
+675
+338% +$15.5K ﹤0.01% 4948
2020
Q2 		$4K Hold
200
– – ﹤0.01% 5585
2020
Q1 		$3K Buy
+200
New +$3.58K ﹤0.01% 5569

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Osaic Holdings's RYTM Position: Q1 2026 in Review

Osaic Holdings reduced its Rhythm Pharmaceuticals (RYTM) stake by 9.6% in Q1 2026, selling an estimated $9.72K and leaving 939 shares worth $81.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4833.

Osaic Holdings first reported a position in RYTM in Q1 2020 and has held it in 25 quarters since. The position peaked at $111K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Osaic Holdings held 939 shares of Rhythm Pharmaceuticals worth $81.7K as of Q1 2026.
  • Osaic Holdings sold 100 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $9.72K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4833 holding.
  • Osaic Holdings first reported a position in Rhythm Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Rhythm Pharmaceuticals position peaked at $111K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.